Elias Karl Mai (Elias K Mai)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 25

Top Venues

Blood cancer journal

Leukemia

British journal of haematology

Cancers

This page only lists publications with an associated author ORCID identifier.

Publications

Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Amelie Boquoi, Aristoteles Giagounidis, Hartmut Goldschmidt, Michael Heinsch, Mathias J Rummel, Nicolaus Kröger, Elias Karl Mai, Judith Strapatsas, Rainer Haas, Guido Kobbe
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384). Cancers 15 (21) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai
Vascular thrombotic events in the era of modern myeloma therapy. British journal of haematology 199 (5) (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martín-Sánchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis-Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Katharina Kriegsmann, Calin Manta, Ricarda Schwab, Elias Karl Mai, Marc S Raab, Hans J Salwender, Roland Fenk, Britta Besemer, Jan Dürig, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Anne M Asemissen, Bernhard Heilmeier, Uta Bertsch, Stefanie Huhn, Carsten Muller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Bone Marrow and Peripheral Blood Aberrant Plasma Cell Assessment by Next-Generation Flow Cytometry in MM Patients. Blood advances (2022)
Mattia D'Agostino, David A Cairns, Juan-José Lahuerta, Ruth Wester, Uta Bertsch, Anders Waage, Elena Zamagni, Maria-Victoria Mateos-Manteca, Daniele Dall'Olio, Niels W C J van de Donk, Graham H Jackson, Serena Rocchi, Hans J Salwender, Joan Bladé Creixenti, Bronno van der Holt, Gastone C Castellani, Francesca Bonello, Andrea Capra, Elias Karl Mai, Jan Dürig, Francesca Gay, Sonja Zweegman, Michele Cavo, Martin F Kaiser, Hartmut Goldschmidt, Jesús María Hernández-Rivas, Alessandra Larocca, Curly T C M Morris, Jesús San F Miguel, Mario Boccadoro, Pieter Sonneveld
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Eva-Maria Klein, Diana Tichy, Hans J Salwender, Elias Karl Mai, Jan Duerig, Katja C Weisel, Axel Benner, Uta Bertsch, Mabast Akhavanpoor, Britta Besemer, Markus Munder, Hans-Walter Lindemann, Dirk Hose, Anja Seckinger, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Marc S Raab, Igor W Blau, Mathias Haenel, Christof Scheid, Hartmut Goldschmidt, null On Behalf Of The German-Speaking Myeloma Multicenter Group Gmmg
Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial. Cancers 13 (19) (2021)
Elias Karl Mai, Thomas Schmitt, Aleksandar Radujkovic, Laila König, Hartmut Goldschmidt, Anthony D Ho, Thomas Luft, Carsten Müller-Tidow, Peter Dreger, Ute Hegenbart, Stefan O Schönland
Submyeloablative total body irradiation-based conditioning and allogeneic stem cell transplantation in high-risk myeloma with early progression after up-front autologous transplantation. British journal of haematology (2021)
Hans J Salwender, Ahmet Elmaagacli, Maximilian Merz, Kaya Miah, Axel Benner, Mathias Haenel, Christian Jehn, Elias Karl Mai, Uta Bertsch, Igor W Blau, Christof Scheid, Dirk Hose, Anja Seckinger, Anna Jauch, Marc S Raab, Steffen P Luntz, Britta Besemer, Markus Munder, Peter Brossart, Stephan Fuhrmann, Hans-Walter Lindemann, Katja C Weisel, Jan Duerig, Hartmut Goldschmidt
Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial. Leukemia 35 (10) (2021)
Marc-Andrea Baertsch, Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Hans J Salwender, Markus Munder, Stephan Fuhrmann, Ulrich Dührsen, Peter Brossart, Kai Neben, Jana Schlenzka, Christina Kunz, Marc S Raab, Jens Hillengaß, Anna Jauch, Anja Seckinger, Dirk Hose, Steffen Luntz, Pieter Sonneveld, Henk Lokhorst, Hans Martin, Martin Goerner, Martin Hoffmann, Hans-Walter Lindemann, Helga Bernhard, Igor W Blau, Christof Scheid, Britta Besemer, Katja C Weisel, Mathias Hänel, Jan Dürig, Hartmut Goldschmidt, null null
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma. Blood cancer journal 11 (1) (2021)
Hartmut Goldschmidt, Elias Karl Mai, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Uta Bertsch, Thomas Hielscher, Maximilian Merz, Markus Munder, Hans-Walter Lindemann, Barbara Hügle-Dörr, Diana Tichy, Nicola Giesen, Dirk Hose, Anja Seckinger, Stefanie Huhn, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Bernhard Rabold, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Martin Hoffmann, Jens Hillengass, Marc S Raab, Igor W Blau, Mathias Hänel, Hans J Salwender, null null
Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial. Leukemia 34 (7) (2020)
Elias Karl Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Markus Munder, Hans-Walter Lindemann, Maximilian Merz, Dirk Hose, Anna Jauch, Anja Seckinger, Steffen Luntz, Sandra Sauer, Stephan Fuhrmann, Peter Brossart, Ahmet Elmaagacli, Martin Goerner, Helga Bernhard, Martin Hoffmann, Marc S Raab, Igor W Blau, Mathias Hänel, Axel Benner, Hans J Salwender, Hartmut Goldschmidt, null null
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age. Leukemia 35 (3) (2020)
Roland Fenk, Aristoteles Giagounidis, Hartmut Goldschmidt, Michael Heinsch, Mathias Rummel, Nicolaus Kroger, Amelie Boquoi, David Lopez, Celina Gerrlich, Julia Baier, Svenja Liesenjohann, Katarzyna Hauck, Ingrida Savickaite, Elias Karl Mai, Carlo Aul, Judith Strapatsas, Ariane Dienst, Mustafa Kondakci, Rainer Haas, Guido Kobbe
Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Maximilian Merz, Thomas Hielscher, David Schult, Elias Karl Mai, Marc S Raab, Jens Hillengass, Anja Seckinger, Dirk Hose, Martin Granzow, Anna Jauch, Hartmut Goldschmidt
Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma. Leukemia 34 (4) (2019)
Katja C Weisel, Christof Scheid, Manola Zago, Britta Besemer, Elias Karl Mai, Mathias Haenel, Jan Duerig, Markus Munder, Hans-Walter Lindemann, Anja Seckinger, Christina Kunz, Axel Benner, Dirk Hose, Anna Jauch, Hans Salwender, Hartmut Goldschmidt
Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: results of the phase II PERSPECTIVE Multiple Myeloma trial. Blood cancer journal 9 (4) (2019)
Maximilian Merz, Thomas Hielscher, Elias Karl Mai, Anja Seckinger, Dirk Hose, Anna Jauch, Sandra Sauer, Steffen Luntz, Uta Bertsch, Marc S Raab, Kai Neben, Hans Salwender, Igor W Blau, Hans-Walter Lindemann, Jan Dürig, Christof Scheid, Mathias Haenel, Katja Weisel, Tim Weber, Stefan Delorme, Hartmut Goldschmidt, Jens Hillengass
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma. Blood cancer journal 9 (9) (2019)
Elias Karl Mai, Eva-Maria Haas, Stephan Lücke, Martin Löpprich, Christina Kunz, Maria Pritsch, Petra Knaup-Gregori, Marc S Raab, Jana Schlenzka, Uta Bertsch, Jens Hillengass, Hartmut Goldschmidt
A systematic classification of death causes in multiple myeloma. Blood cancer journal 8 (3) (2018)
Elias Karl Mai, Thomas Hielscher, Uta Bertsch, Jana Schlenzka, Hans J Salwender, Markus Munder, Christian Gerecke, Ulrich Dührsen, Peter Brossart, Kai Neben, Jens Hillengass, Marc S Raab, Maximilian Merz, Marc-Andrea Baertsch, Anna Jauch, Dirk Hose, Hans Martin, Hans-Walter Lindemann, Igor W Blau, Christof Scheid, Katja C Weisel, Hartmut Goldschmidt, null null
Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma. Leukemia 33 (1) (2018)
Maximilian Merz, Thomas Hielscher, Anja Seckinger, Dirk Hose, Elias Karl Mai, Marc S Raab, Hartmut Goldschmidt, Anna Jauch, Jens Hillengass
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myeloma. American journal of hematology 91 (11) (2016)
Elias Karl Mai, Thomas Hielscher, Jost K Kloth, Maximilian Merz, Sofia Shah, Michaela Hillengass, Barbara Wagner, Dirk Hose, M S Raab, Anna Jauch, Stefan Delorme, Hartmut Goldschmidt, Marc-André Weber, Jens Hillengass
Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology. European radiology 26 (11) (2016)
Elias Karl Mai, Axel Benner, Uta Bertsch, Peter Brossart, Annette Hänel, Volker Kunzmann, Ralph Naumann, Kai Neben, Gerlinde Egerer, Anthony D Ho, Jens Hillengass, Marc-Steffen Raab, Andreas Neubauer, Astrid Peyn, Yon-Dschun Ko, Norma Peter, Christof Scheid, Hartmut Goldschmidt
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial. British journal of haematology 173 (5) (2016)

Elias Karl Mai.css-eqlu8i{font-size:small;padding-left:4px;} (Elias K Mai)

Publication Activity (10 Years)

Top Topics

Top Venues

Elias Karl Mai (Elias K Mai)